Zealand Pharma A/S (ZEAL) Social Stream



Zealand Pharma A/S (ZEAL): $17.59

0.21 (+1.21%)

POWR Rating

Component Grades

Momentum

NR

Stability

NR

Sentiment

Quality

NR

Add ZEAL to Watchlist
Sign Up

ZEALAND PHARMA A (ZEAL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ZEAL.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-09-16 1 $35 $35 $35 $17.59 98.98%
2021-11-15 1 $28.5 $28.5 $28.5 $17.59 62.02%
2022-01-11 1 $30.5 $30.5 $30.5 $17.59 73.39%
2022-03-14 1 $26.5 $26.5 $26.5 $17.59 50.65%
2022-05-16 1 $21 $21 $21 $17.59 19.39%
2022-08-16 1 $22.5 $22.5 $22.5 $17.59 27.91%

Price Target Last Issued August 16, 2022

The Trend in the Analyst Price Target


Over the past 48 weeks, ZEAL's average price target has gone down $12.5.

Over the past 39 weeks, ZEAL's average upside potential has been 60.22%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-15 1 28.5 28.5 28.5 24.66 15.57%
2022-01-11 1 30.5 30.5 30.5 21.74 40.29%
2022-03-14 1 26.5 26.5 26.5 12.14 118.29%
2022-05-16 1 21.0 21.0 21.0 10.05 108.96%
2022-08-16 1 22.5 22.5 22.5 19.07 17.99%

ZEAL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 48 weeks, ZEAL's average broker recommendation rating improved by 2.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ZEALAND PHARMA A's number of analysts covering the stock is greater than 3.96% of all US stocks.
  • ZEAL has a lower variance in analysts' estimates than 88.88% of Pharmaceutical Products stocks.
  • ZEAL has a greater upside potential (average analyst target price relative to current price) than 163.95% of Pharmaceutical Products stocks.
  • In terms of how ZEALAND PHARMA A fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 474.67% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ZEALAND PHARMA A are XOMA, XLO, and XERS.

Is ZEAL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!